Literature DB >> 12452375

Symptom-to-diagnosis interval and survival in cancers of the digestive tract.

Esteve Fernandez1, Miquel Porta, Núria Malats, Josep Belloc, Manuel Gallén.   

Abstract

The objective was to identify the main correlates of the symptom-to-diagnosis interval (SDI) and to analyze their influence upon the survival in patients with cancers of the digestive tract. Two hundred forty-eight symptomatic patients with cancer of the esophagus (N = 31), stomach (N = 70), colon (N = 84), and rectum (N = 66) were interviewed and prospectively followed (median follow-up of 77 months). Cox's regression was used to assess the relative risk (RR) of death according to SDI. The median SDI was about 4 months, with nonsignificant differences by sex, age, social class, family history of cancer, or tumor site. The RR of death varied significantly by age (P = 0.012), tumor site (P < 0.01), tumor stage (P < 0.01), and type of hospital admission (P < 0.01). After adjustment for known and potential predictors of survival and as compared to an SDI < 2.5 months, the RR of death was 0.89 (95% CI: 0.61-1.32) for an SDI of 2.5-6 months, 0.78 (95% CI: 0.49-1.26) for SDI > 6-12 months, and 0.81 (95% CI: 0.44-1.49) for SDI > 12 months. These results do not imply that specific actions to hasten diagnosis must of necessity be ineffective, but underscore what a challenging task the secondary prevention of cancer remains.

Entities:  

Mesh:

Year:  2002        PMID: 12452375     DOI: 10.1023/a:1020535304670

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Relation between socioeconomic status and tumour stage in patients with breast, colorectal, ovarian, and lung cancer: results from four national, population based studies.

Authors:  D H Brewster; C S Thomson; D J Hole; R J Black; P L Stroner; C R Gillis
Journal:  BMJ       Date:  2001-04-07

2.  Is the two week rule for cancer referrals working?

Authors:  R Jones; G Rubin; P Hungin
Journal:  BMJ       Date:  2001-06-30

3.  Canada sends patients with cancer to United States.

Authors:  D Spurgeon
Journal:  BMJ       Date:  1999-06-05

4.  Carcinoma of the oesophagus: factors influencing survival.

Authors:  J D Younghusband; A P Aluwihare
Journal:  Br J Surg       Date:  1970-06       Impact factor: 6.939

5.  Delay in diagnosis of gastric cancer: a prospective study evaluating doctors'- and patients' delay and its influence on five year survival.

Authors:  T L Zilling; B S Walther; B Ahren
Journal:  Anticancer Res       Date:  1990 Mar-Apr       Impact factor: 2.480

6.  Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites.

Authors:  M Porta; M Gallén; N Malats; J Planas
Journal:  J Epidemiol Community Health       Date:  1991-09       Impact factor: 3.710

7.  Evolutive and prognostic aspects in gastric cancer. Analysis of 189 cases.

Authors:  A Ziliotto; J E Kunzle; A De Souza; O Colicchio-Filho
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

8.  Clinical and pathologic prognostic indicators in colorectal cancer. A population-based study.

Authors:  M Ponz de Leon; M Sant; A Micheli; C Sacchetti; C Di Gregorio; R Fante; G Zanghieri; G Melotti; G Gatta
Journal:  Cancer       Date:  1992-02-01       Impact factor: 6.860

9.  Disagreement between hospital medical records and a structured patient interview on the type and date of the first symptom in cancers of the digestive tract.

Authors:  N Malats; J Belloc; M Gallén; M Porta
Journal:  Rev Epidemiol Sante Publique       Date:  1995-12       Impact factor: 1.019

10.  Emergency admission for cancer: a matter of survival?

Authors:  M Porta; E Fernandez; J Belloc; N Malats; M Gallén; J Alonso
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

View more
  17 in total

1.  Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage.

Authors:  Miquel Porta; Xavier Fabregat; Núria Malats; Luisa Guarner; Alfredo Carrato; Ana de Miguel; Laura Ruiz; Manuel Jariod; Sergi Costafreda; Susana Coll; Juan Alguacil; Josep M Corominas; Ricard Solà; Antonio Salas; Francisco X Real
Journal:  Clin Transl Oncol       Date:  2005-06       Impact factor: 3.405

2.  Timing of blood extraction in epidemiologic and proteomic studies: results and proposals from the PANKRAS II Study.

Authors:  Miquel Porta; José Pumarega; Olga Ferrer-Armengou; Tomàs López; Joan Alguacil; Núria Malats; Esteve Fernàndez
Journal:  Eur J Epidemiol       Date:  2007-07-18       Impact factor: 8.082

3.  Caution: work in progress : While the methodological "revolution" deserves in-depth study, clinical researchers and senior epidemiologists should not be disenfranchised.

Authors:  Miquel Porta; Francisco Bolúmar
Journal:  Eur J Epidemiol       Date:  2016-07-14       Impact factor: 8.082

Review 4.  Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

Authors:  Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

5.  Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.

Authors:  Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

6.  Delayed treatment for rectal cancer.

Authors:  Stephen L Ristvedt; Elisa H Birnbaum; David W Dietz; James W Fleshman; Ira J Kodner; Thomas E Read
Journal:  Dis Colon Rectum       Date:  2005-09       Impact factor: 4.585

7.  Detection of early gastric cancer: misunderstanding the role of mass screening.

Authors:  Haruhisa Suzuki; Takuji Gotoda; Mitsuru Sasako; Daizo Saito
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

8.  Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia.

Authors:  Ziad F Gellad; Daniel Almirall; Dawn Provenzale; Deborah A Fisher
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

Review 9.  Role of symptoms in diagnosis and outcome of gastric cancer.

Authors:  Giovanni Maconi; Gianpiero Manes; Gabriele-Bianchi Porro
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

10.  Compliance with the 62-day target does not improve long-term survival.

Authors:  Ronak Patel; John E Anderson; Claire McKenzie; Mhairi Simpson; Nina Singh; Fredrick Ruzvidzo; Praveen Sharma; Roy Scott; Angus MacDonald
Journal:  Int J Colorectal Dis       Date:  2017-11-03       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.